Why do eosinophils stain red

Overview

Eosinophils are a type of granulocyte, comprising 1-6% of circulating white blood cells in healthy individuals, that play crucial roles in immune responses against parasites and in allergic reactions. Their name derives from their staining properties with eosin dye, first systematically described by German physician-scientist Paul Ehrlich in 1879. Ehrlich's pioneering work in hematology involved using acidic and basic dyes to differentiate blood cells, leading to the classification of eosinophils, basophils, and neutrophils based on their staining characteristics. Historically, this discovery was part of Ehrlich's broader contributions to immunology and chemotherapy, for which he received the Nobel Prize in Physiology or Medicine in 1908. The standard staining technique today, Romanowsky staining (including Wright-Giemsa methods developed in the early 1900s), continues to rely on eosin's interaction with eosinophil granules for clinical diagnosis. In modern medicine, eosinophil counts above 500 cells/μL (eosinophilia) indicate potential allergic conditions, parasitic infections, or certain malignancies, making their identification through staining essential for diagnostic hematology.

How It Works

The red staining of eosinophils occurs through electrostatic interactions between acidic dyes and basic proteins within their cytoplasmic granules. Eosinophils contain specific granules storing four main cationic proteins: major basic protein (MBP, 5-10 μg/10⁶ cells), eosinophil cationic protein (ECP, 10-20 μg/10⁶ cells), eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN). These proteins have high isoelectric points (pI 10-11), making them strongly basic and positively charged at physiological pH. In Romanowsky staining, eosin Y (an acidic xanthene dye with negative charge) is applied at pH 6.8-7.2, creating ionic bonds with the positively charged amino groups (particularly arginine and lysine residues) in these granule proteins. The staining process involves fixing blood smears with methanol, then applying eosin-methylene blue solutions that allow differential staining: eosin binds to eosinophil granules (red), while methylene blue stains basophilic components (blue). Under light microscopy at 400-1000× magnification, eosinophils display bright red-orange granules against a pale blue cytoplasm, with the intensity varying with granule maturity and protein content.

Why It Matters

The characteristic red staining of eosinophils has significant clinical and diagnostic importance in modern medicine. In clinical hematology, it enables rapid identification and quantification of eosinophils in complete blood counts (CBC), where normal ranges are 0-500 cells/μL. Elevated eosinophil counts (eosinophilia) detected through staining help diagnose conditions like asthma (where eosinophils may reach 5-15% of white blood cells), parasitic infections (e.g., helminth infections causing counts >1500 cells/μL), and eosinophilic disorders such as hypereosinophilic syndrome. The staining also aids in distinguishing eosinophils from other granulocytes in bone marrow aspirates and tissue biopsies, crucial for diagnosing hematological malignancies like eosinophilic leukemia. Beyond diagnostics, understanding eosinophil staining properties has facilitated research into their immune functions, particularly their role in releasing cytotoxic granule proteins that combat parasites but also contribute to tissue damage in allergic diseases. This knowledge has led to targeted therapies, including monoclonal antibodies like mepolizumab (approved 2015) that reduce eosinophil levels in severe asthma by targeting interleukin-5.